Ranbaxy withdraws 27 drugs from US market
Drug major Ranbaxy Laboratories ( Get Quote ) on Wednesday said it has withdrawn 27 drugs from the US market due to commercial reasons.
Ranbaxy Pharmaceuticals has halted productions of its generic version of the cholesterol drug Lipitor after recalling a second batch of tablets in the 10mg, 20mg, and 40mg dosage strengths.